Back
HFA Premium Access

Low dose of basiliximab for induction immunosuppresion therapy for heart transplant results in favourable outcomes

Session: Poster Session 1 - Advanced heart failure
Topic: Advance heart failure
Speaker: Doctor V. kittipibul (Durham, US)
Event: Heart Failure 2017 - 4th World Congress on Acute Heart Failure

Congress Presentation

Add to my library

Like

About the speaker

Doctor Veraprapas kittipibul

Duke University Health System, Durham (United States of America)
0 follower

7 more presentations in this session

Influence of a continuous veno-venous hemofiltration on the long-term prognosis in patients with an advanced heart failure and an acute coronary syndrome

Speaker: Doctor O. Trebacz (Krakow, PL)

Access
Abstract
Like
Thumbnail

Beta-blockers uptitration between infusions predicts event-free survival in advanced heart failure treated with repeated cures of low-dose levosimendan

Speaker: Doctor P. Yerly (Lausanne, CH)

Access
Abstract
Like
Thumbnail

Utility of cTnT-hs and sAXL for prognosis evaluation after heart transplantation

Speaker: Doctor S. Mirabet Perez (Barcelona, ES)

Access
Abstract
Like
Thumbnail

Predictors of mortality at six months after in advanced heart failure patients attended in primary care

Speaker: Doctor J. Verdu (Barcelona, ES)

Access
Abstract
Like
Thumbnail

Intermitent treatment with levosimendan in outpatients with chronic advanced heart failure: our experience.

Speaker: Doctor J. Garcia Pinilla (Malaga, ES)

Access
Slides
Like
Thumbnail

Access the full session

Poster Session 1 - Advanced heart failure

Speakers: Doctor V. kittipibul, Doctor O. Trebacz, Doctor P. Yerly, Doctor S. Mirabet Perez, Doctor J. Verdu...
Access
Like
Thumbnail

About the event

Image

Heart Failure 2017 - 4th World Congress on Acute Heart Failure

29 April - 2 May 2017

Sessions Presentations

Congress
logo Image

ESC 365 is supported by

logo Bristol Myers Squibb Explore sponsored resources
logo Novo Nordisk Explore sponsored resources